Latest From Biotech Now

FDA: How can we improve it?

Stephen Sherwin MD

By Stephen Sherwin, Former Chairman of BIO As Congress and the President work together to hammer out a new, national economic roadmap, it is important to point out to those working in, and interested in, our industry that we too have recently assembled a roadmap – one designed to fully realize the promise our industry holds for people everywhere. Several weeks ago, at the 2011 BIO International Convention in Washington, DC, BIO unveiled its first ever 5 Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Senate Hearing Focuses on Biobased Product Potential for Rural Job Creation

capital building

The Senate Agriculture Committee today held a hearing on “Growing Jobs in Rural America” (watch the webcast). Dr. Marc Verbruggen, President and CEO of NatureWorks LLC based in Wayzata, Minn., and Dr. Oliver P. Peoples, Founder and Chief Scientific Officer of Metabolix, Inc. based in Cambridge, Mass., both BIO members, testified about their companies’ plans for growth and job creation. Sen. Debbie Stabenow (D-Mich.), chair of the committee, “called the rural economy a bright spot Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Convention rookie no longer

2011 BIO International Convention Exhibition

As the saying goes, there is nothing quite like learning on the job and no truer words could be spoken about my experience with this year’s BIO International Convention. Having joined the Communications Department less than two months prior to the largest event of the year, my start date was in the height of Convention preparation. Each day at the office was consumed by learning, retaining and contributing as much as possible to the Convention Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Taiwan’s Translational Research (or lack thereof)

Taiwan Flag - Matthew Fang

Brady Huggett concludes in this article that, “… perhaps the biggest strike against Taiwan is a lack of translational research. There is no collective mindset that envisions products from research. And if biotech is to drive the future economies of countries around the globe, there has to be nationwide efforts to turn academic research and publicly-funded lab work into something that can benefit patients and be sold. We’ve talked about it before on this blog Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Myriad Genetics’ actions justify a ban on gene patents?

Virus

The following information was provided by Myriad’s General Counsel during his presentation on the subject during a recent BIO IP conference: In order to develop and then ensure the widest possible distribution of the Myriad BRCA diagnostic test, Myriad needed to make the initial discovery, educate the medical community on the values of personalized medicine (the BRCA test), convince insurance companies to cover the test, and educate the patient community.  All of these activities took Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,